Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.40 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.39 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.38 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.37 |
| ▸ | ERN1 | O75460 | 1/20 | 0.37 |
| ▸ | PDE9A | O76083 | 1/20 | 0.36 |
| ▸ | IKBKB | O14920 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30413770 | 1.00 | ESR1 (0.41) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL30761752 | 0.89 | ALDH1A1 (0.41) | ALOX5CYP1A2CYP2D6CYP2C9TSHR | |
| SCHEMBL29350362 | 0.80 | ESR1 (0.52) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL36279 | 0.80 | ESR1 (0.52) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL2379728 | 0.80 | ESR1 (0.52) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL5556127 | 0.80 | MGLL (0.41) | ESR1ESR2CA1CA2 | |
| SCHEMBL2447870 | 0.79 | ACHE (0.38) | ESR1ESR2CA1CA2GPR84 | |
| SCHEMBL25060858 | 0.78 | ESR1 (0.50) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| SCHEMBL25566510 | 0.78 | ESR1 (0.50) | ESR1ESR2ALOX5HSD17B1HSD17B2 | |
| Methane SCHEMBL27979911 | 0.78 | ESR1 (0.50) | ESR1ESR2ALOX5HSD17B1HSD17B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2261302-B2 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ANTHRACENE DERIVATIVE | IDEMITSU KOSAN CO (JP) | 2019-05-08 | — | — | EP | disclosed |
| US-20170125687-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ANTHRACENE DERIVATIVE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-05-04 | — | — | US | disclosed |
| US-9583716-B2 | Organic electroluminescence device and anthracene derivative | IDEMITSU KOSAN CO., LTD. (JP) | 2017-02-28 | — | — | US | disclosed |
| EP-2261302-B1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ANTHRACENE DERIVATIVE | IDEMITSU KOSAN CO (JP) | 2016-04-20 | — | — | EP | disclosed |
| EP-2145937-B2 | Organic electroluminescence device and anthracene derivative | IDEMITSU KOSAN CO (JP) | 2016-03-02 | — | — | EP | disclosed |
| US-20140291653-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ANTHRACENE DERIVATIVE | IDEMITSU KOSAN CO., LTD. (JP) | 2014-10-02 | — | — | US | disclosed |
| US-8785006-B2 | Organic electroluminescence device and anthracene derivative | IDEMITSU KOSAN CO., LTD. (JP) | 2014-07-22 | — | — | US | disclosed |
| US-8318324-B2 | Organic electroluminescence device and anthracene derivative | IDEMITSU KOSAN CO., LTD. (JP) | 2012-11-27 | — | — | US | disclosed |
| US-20120235561-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ANTHRACENE DERIVATIVE | IDEMITSU KOSAN CO., LTD. (JP) | 2012-09-20 | — | — | US | disclosed |
| EP-2145937-B1 | Organic electroluminescence device and anthracene derivative | IDEMITSU KOSAN CO (JP) | 2012-04-25 | — | — | EP | disclosed |
| US-20110034744-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ANTHRACENE DERIVATIVE | IDEMITSU KOSAN CO., LTD. (JP) | 2011-02-10 | — | — | US | disclosed |
| EP-2261302-A1 | Organic electroluminescence device and anthracene derivative | Idemitsu Kosan Co., Ltd. (JP) | 2010-12-15 | — | — | EP | disclosed |
| US-7839074-B2 | A light emitting thin film between the cathode and the anode,which comprises an anthracene derivative, for example, 9-(4-(fluoroanthen-3-yl)phenyl)-),10-(fluoranthen-3-yl)-anthracene; also an aryamine compound such as TBDB; great efficiency of light emission, having a long life | IDEMITSU KOSAN CO., LTD. (JP) | 2010-11-23 | — | — | US | disclosed |
| EP-2145937-A1 | Organic electroluminescence device and anthracene derivative | Idemitsu Kosan Co., Ltd. (JP) | 2010-01-20 | — | — | EP | disclosed |
| EP-1553154-B1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ANTHRACENE DERIVATIVE | IDEMITSU KOSAN CO (JP) | 2009-12-23 | — | — | EP | disclosed |
| US-20060043858-A1 | Organic electroluminescence device and anthracene derivative | IDEMITSU KOSAN CO., LTD. (JP) | 2006-03-02 | — | — | US | disclosed |
| EP-1553154-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ANTHRACENE DERIVATIVE | IDEMITSU KOSAN CO., LTD. (JP) | 2005-07-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110034744-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ANTHRACENE DERIVATIVE | ALKBH2, DNA2, ANXA7 | ESR1 14/4885ESR2 94/4885ALOX5 808/4885 |
| US-20170125687-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ANTHRACENE DERIVATIVE | ALKBH2, L1CAM, ALKBH3 | ESR1 42/4885ESR2 80/4885ALOX5 1764/4885 |
| US-20120235561-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ANTHRACENE DERIVATIVE | ALKBH2, DNA2, ANXA7 | ESR1 14/4885ESR2 94/4885ALOX5 808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.